Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Anas Younes, Joshua Brody, Cecilia Carpio, Armando Lopez-Guillermo, Dina Ben-Yehuda, Burhan Ferhanoglu, Arnon Nagler, Muhit Ozcan, Irit Avivi, Francesc Bosch, Maria Dolores Caballero Barrigón, Andrzej Hellmann, Bryone Kuss, David D.F. Ma, Fatih Demirkan, Münci Yağci, Netanel A. Horowitz, Paula Marlton, Raul Cordoba, Tomasz WrobelDaniela Buglio, Michael Streit, Brendan P. Hodkinson, Michael Schaffer, John Alvarez, Rob Ceulemans, Sriram Balasubramanian, Jan de Jong, Shean Sheng Wang, Nele Fourneau, Wojciech Jurczak
Research output: Contribution to journal › Article › peer-review
159Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study'. Together they form a unique fingerprint.